3-Phenoxybenzaldehyde
C1s-IN-1
N-((Allyloxy)carbonyl)-N-methyl-L-alanine
Crovalimab
Pexelizumab
Olendalizumab
Pozelimab
Gavilimomab
Gefurulimab
Vilobelimab
Avdoralimab
Lampalizumab
Tesidolumab
Ravulizumab
Vesencumab
Eculizumab
Sutimlimab
Riliprubart
Empasiprubart
C5a Receptor agonist, W5Cha